Publicaciones en las que colabora con Jesús Egido de los Ríos (12)

2022

  1. The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice

    Antioxidants, Vol. 11, Núm. 12

2014

  1. IL-17A is a novel player in dialysis-induced peritoneal damage

    Kidney International, Vol. 86, Núm. 2, pp. 303-315

2013

  1. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells

    Nephron - Experimental Nephrology, Vol. 122, Núm. 1-2, pp. 62-74

2012

  1. Angiotensin II contributes to renal fibrosis independently of notch pathway activation

    PLoS ONE, Vol. 7, Núm. 7

2010

  1. Regulation of vascular and renal cells by common mediators in health and disease: Role of the renin-angiotensin system in the pathophysiology of hypertension and cardiovascular disease

    Cardiorenal Syndrome: Mechanisms, Risk and Treatment (Springer Milan), pp. 49-63

  2. Statins inhibit angiotensin II/smad pathway and related vascular fibrosis, by a TGF-β-independent process

    PLoS ONE, Vol. 5, Núm. 11

2009

  1. CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-κB

    Journal of the American Society of Nephrology, Vol. 20, Núm. 7, pp. 1513-1526

2008

  1. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation

    Kidney International, Vol. 74, Núm. 5, pp. 585-595

  2. Essential role of TGF-β/Smad pathway on statin dependent vascular smooth muscle cell regulation

    PLoS ONE, Vol. 3, Núm. 12

  3. Inhibitory effect of interleukin-1β on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells

    American Journal of Physiology - Renal Physiology, Vol. 294, Núm. 1

  4. Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways

    Pharmaceutical Research, Vol. 25, Núm. 10, pp. 2447-2461

2007

  1. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: Role of RhoA/ROCK and MAPK pathways

    Hypertension, Vol. 50, Núm. 2, pp. 377-383